Transpek Industry Past Earnings Performance
Past criteria checks 1/6
Transpek Industry's earnings have been declining at an average annual rate of -3.6%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been growing at an average rate of 6.7% per year. Transpek Industry's return on equity is 4.9%, and it has net margins of 6.2%.
Key information
-3.6%
Earnings growth rate
-5.0%
EPS growth rate
Chemicals Industry Growth | 17.7% |
Revenue growth rate | 6.7% |
Return on equity | 4.9% |
Net Margin | 6.2% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Transpek Industry makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 6,181 | 386 | 661 | 0 |
30 Jun 24 | 5,693 | 320 | 623 | 0 |
31 Mar 24 | 5,867 | 386 | 627 | 0 |
31 Dec 23 | 6,410 | 553 | 616 | 0 |
30 Sep 23 | 6,892 | 639 | 622 | 0 |
30 Jun 23 | 7,844 | 829 | 627 | 0 |
31 Mar 23 | 8,338 | 835 | 613 | 0 |
31 Dec 22 | 7,716 | 724 | 577 | 0 |
30 Sep 22 | 7,552 | 707 | 551 | 0 |
30 Jun 22 | 6,889 | 683 | 532 | 0 |
31 Mar 22 | 6,039 | 654 | 517 | 0 |
31 Dec 21 | 5,464 | 650 | 496 | 0 |
30 Sep 21 | 4,761 | 501 | 479 | 0 |
30 Jun 21 | 4,090 | 331 | 457 | 0 |
31 Mar 21 | 3,455 | 233 | 452 | 0 |
31 Dec 20 | 4,176 | 366 | 481 | 0 |
30 Sep 20 | 4,923 | 585 | 491 | 0 |
30 Jun 20 | 5,443 | 734 | 486 | 0 |
31 Mar 20 | 5,793 | 729 | 507 | 0 |
31 Dec 19 | 5,855 | 788 | 588 | 0 |
30 Sep 19 | 5,861 | 633 | 572 | 0 |
30 Jun 19 | 5,928 | 585 | 564 | 0 |
31 Mar 19 | 6,096 | 657 | 547 | 0 |
31 Mar 18 | 3,666 | 264 | 413 | 0 |
31 Mar 17 | 3,166 | 300 | 381 | 0 |
31 Mar 16 | 2,837 | 213 | 351 | 0 |
31 Mar 15 | 2,896 | 220 | 330 | 0 |
31 Mar 14 | 2,692 | 75 | 529 | 0 |
Quality Earnings: 506687 has high quality earnings.
Growing Profit Margin: 506687's current net profit margins (6.2%) are lower than last year (9.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 506687's earnings have declined by 3.6% per year over the past 5 years.
Accelerating Growth: 506687's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 506687 had negative earnings growth (-39.6%) over the past year, making it difficult to compare to the Chemicals industry average (8%).
Return on Equity
High ROE: 506687's Return on Equity (4.9%) is considered low.